Apotex Health Corp's stock has seen notable declines this week amidst no major news.
This week, Apotex Health Corp (APTX.TO) experienced a decrease in share price, closing at C$33.98, down 3.94% on the day and 8.64% over the week. The stock has faced challenges despite a year-to-date gain of 24.18%. Investors may be looking for clarity on the company's future performance as it navigates market conditions.
Advertisement
Apotex Health Corp
APTX.TO
APTX.TO
Apotex Health Corp
WealthAwesomeMarket cap
$7.54B
52W high
$40.11
52W low
$26.01
1W change
+2.34%
Analyst Price Targets
Based on analyst covering APTX · as of Sep 23, 2026
Wall Street analysts forecast APTX stock price to rise 22.9% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$41.37
+22.9% Upside
Previously C$41.23 on Sep 17, 2026
Current Price
C$33.65
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on APTX's historical volatility
30-Day Vol
46.3%
Annualized
90-Day Vol
49.6%
Annualized
Trend (90d)
+0.5%
Annualized drift
90d Mean
C$33.71
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$33.67 | C$28.70 – C$39.50 |
| 60 trading days | C$33.69 | C$26.88 – C$42.23 |
| 90 trading days | C$33.71 | C$25.56 – C$44.46 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: With Apotex Health Corp's recent price action reflecting a decline and no significant news to drive the stock, investors should consider the company's fundamentals and technical indicators while evaluating future investment decisions.
Bull case
Analysts have a positive outlook for Apotex Health Corp, with an average target price of C$41.27, suggesting there could be upside from current levels. The recent investment-grade rating and credit agreement may also strengthen its financial stability.
Bear case
On the downside, the stock has been under pressure, showing a profit margin of -0.9% and a negative EPS. These factors may raise concerns about profitability and operational efficiency.
Price Action
Apotex Health Corp's stock closed at C$33.98, reflecting a loss of 3.94% on the day and a decline of 8.64% over the week. Year-to-date, the stock has gained 24.18%, but recent price movements raise questions about its near-term trajectory.
Advertisement
Catalysts and Company News
There were no significant news announcements from Apotex Health Corp this week that could explain the stock's decline. However, the company has been in the headlines previously regarding its initial public offering (IPO) filings and credit agreements, which may have influenced market sentiment.
Technical Picture
Currently, Apotex Health Corp's stock is trading below both its 50-day and 200-day moving averages, both at C$34.49. The stock's 52-week range is C$26.05 to C$40.18, with the current price at approximately 56% of this range. The recent volume of 74,874 shares is notably lower than the 20-day average of 410,250 shares, indicating decreased trading activity.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
